Invention Grant
US08399426B2 Method for treating breast cancer using adenine nucleotide translocator 2 (ANT2) siRNA or ANT2 shRNA
有权
使用腺嘌呤核苷酸转运蛋白2（ANT2）siRNA或ANT2 shRNA治疗乳腺癌的方法
- Patent Title: Method for treating breast cancer using adenine nucleotide translocator 2 (ANT2) siRNA or ANT2 shRNA
- Patent Title (中): 使用腺嘌呤核苷酸转运蛋白2（ANT2）siRNA或ANT2 shRNA治疗乳腺癌的方法
-
Application No.: US13030860Application Date: 2011-02-18
-
Publication No.: US08399426B2Publication Date: 2013-03-19
- Inventor: Chul Woo Kim , Ji Young Jang
- Applicant: Chul Woo Kim , Ji Young Jang
- Applicant Address: KR Seoul
- Assignee: Bioinfra Inc.
- Current Assignee: Bioinfra Inc.
- Current Assignee Address: KR Seoul
- Agency: Lucas & Mercanti, LLP
- Priority: KR10-2006-0032823 20060411
- Main IPC: A61K31/70
- IPC: A61K31/70 ; C07H21/04
Abstract:
The present invention relates to adenine nucleotide translocator 2 (ANT2) siRNA (small interfering RNA) or ANT2 shRNA (short hairpin RNA) suppressing the expression of ANT2 gene expression and anticancer agent containing the same. Furthermore, the present invention relates to methods for treating breast cancers or stem cells of a breast cancer by treating the same with ANT2 siRNA or ANT2 shRNA. In addition, the invention provides a method for inhibiting metastasis of breast cancer cells with ANT2 siRNA or ANT2 shRNA.
Public/Granted literature
- US20110207798A1 METHOD FOR TREATING BREAST CANCER USING ADENINE NUCLEOTIDE TRANSLOCATOR 2 (ANT2) SIRNA OR ANT2 SHRNA Public/Granted day:2011-08-25
Information query
